Int J Chron Obstruct Pulmon Dis. 2025 Jul 3;20:2173-2182. doi: 10.2147/COPD.S518455. eCollection 2025.
ABSTRACT
BACKGROUND: The gut-lung axis, representing the communication between gut microbiota and the lungs, has been hypothesized to influence chronic obstructive pulmonary disease (COPD) development through modulation of the immune response. However, the causal role of gut microbiota in COPD and the potential mediating role of immune cells remain largely undetermined. This study aimed to uncover the causal relationship between gut microbiota and COPD and explore the potential mediating role of immune cells in this connection.
METHODS: This study employed a two-step Mendelian randomization (MR) analysis to investigate the causal effect of gut microbiota on COPD and explore the potential mediating role of immune cells in this relationship. The inverse variance weighted method served as the primary MR analysis method.
RESULTS: MR analyses revealed statistically significant genetic associations between 28 gut microbiota and COPD. Among these, the genus Coprococcus demonstrated the strongest causal effect on COPD risk, exhibiting a significant positive association (odds ratio (OR) = 1.18, 95% confidence interval (CI): 1.03-1.36, P = 0.03). Additionally, 15 immune cell traits displayed significant associations with Coprococcus. Notably, CD27 expressed on IgD– CD38– B cells emerged as a potential contributor to COPD development (OR = 1.04, 95% CI: 1.00-1.07, P = 0.03). We further explored the potential mediating effect of CD27 on IgD– CD38– B cells in the relationship between Coprococcus and COPD.
CONCLUSION: Our MR analysis provided evidence for a causal association between gut microbiota and COPD, potentially mediated by immune cells.
PMID:40626314 | PMC:PMC12232946 | DOI:10.2147/COPD.S518455